- slide1
- slide2
Overview
The life sciences industry is undergoing a digital transformation fuelled by the need to accelerate research, enhance patient outcomes, and navigate complex regulatory landscapes. While advanced technologies like AI, machine learning, and automation promise to drive this change, organizations still face hurdles from outdated, incomplete, and low-quality data that hinder effective integration. The ISG Provider Lens® Life Sciences Digital Services 2025 study examines how digital transformation solutions and services are reshaping the industry to overcome these challenges and unlock new opportunities. LTM is recognized as a Leader in Manufacturing Supply Chain (Service Providers) and a Rising Star in Clinical Development (Service Providers).
LTM has been identified as a “Leader” in ISG’s Provider Lens® Life Sciences Digital Services 2025 evaluation for Manufacturing Supply Chain (Service Providers) quadrant.
ISG recognized LTM’s strengths in seamlessly integrating IT/OT, using AI for predictive analytics, ensuring regulatory compliance, and driving end-to-end digital optimization in life sciences manufacturing and supply chain.
" LTM seamlessly uses IT and OT to transform manufacturing supply chains in life sciences with innovative solutions that drive efficiency and compliance. "
– Sneha Jayanth , Senior Research Analyst ISG
Key Strengths
LTM has been identified as a “Rising Star” in ISG’s Provider Lens® 2025 evaluation for Clinical Development (Service Providers) quadrant.
LTM’s agentic AI solutions enhance operational efficiency and strategic decision-making across the clinical value chain — a capability ISG has recognized as one of its key strengths in this space.
“LTM transforms clinical development through innovative solutions and advanced technologies, enhancing patient engagement and operational efficiency to deliver timely, high-quality outcomes in clinical trials.”
– Rohan Sinha , Principal Analyst ISG